Literature DB >> 9869321

Normal and pathological aging--findings of positron-emission-tomography.

R Mielke1, J Kessler, B Szelies, K Herholz, K Wienhard, W D Heiss.   

Abstract

Normal aging of the brain is predominantly characterized by metabolic changes in the prefrontal cortex. While in middle age there is a trend to hyperfrontality, PET demonstrates in old age a decline of regional cerebral glucose metabolism in frontal areas. In progeric diseases, clinically apparent as premature aging, the metabolic pattern is similar like in normal aging but qualitatively more severe. In patients with the diagnosis of probable Alzheimer's disease (AD) hypometabolism in early dementia is typically present in heteromodal association areas. Hypometabolism then spreads to other cortical and subcortical regions suggesting a characteristic pattern of degeneration that reflects selective vulnerability within limbic-cortical networks. Synaptic plasticity, clinically apparent as cognitive reserve capacity, can be assessed by PET under specific cognitive activation. In AD it is reduced in comparison to age-matched normals and may be influenced by drugs giving trophic support to neurochemical systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869321     DOI: 10.1007/s007020050097

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

Review 2.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

3.  Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.

Authors:  Y Zhang; N Schuff; G-H Jahng; W Bayne; S Mori; L Schad; S Mueller; A-T Du; J H Kramer; K Yaffe; H Chui; W J Jagust; B L Miller; M W Weiner
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

5.  Metabolic connectivity as index of verbal working memory.

Authors:  Na Zou; Gael Chetelat; Mustafa G Baydogan; Jing Li; Florian U Fischer; Dmitry Titov; Juergen Dukart; Andreas Fellgiebel; Mathias Schreckenberger; Igor Yakushev
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

6.  Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Authors:  Natalie C Kaiser; Rebecca J Melrose; Collin Liu; David L Sultzer; Elvira Jimenez; Michael Su; Lorena Monserratt; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-09-17       Impact factor: 2.035

7.  Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele.

Authors:  Sun Mi Kim; Min Ji Kim; Hak Young Rhee; Chang-Woo Ryu; Eui Jong Kim; Esben Thade Petersen; Geon-Ho Jahng
Journal:  Neuroradiology       Date:  2012-07-25       Impact factor: 2.804

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Authors:  Hwamee Oh; Cindee Madison; Suzanne Baker; Gil Rabinovici; William Jagust
Journal:  Brain       Date:  2016-05-13       Impact factor: 13.501

10.  Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine.

Authors:  Diane M Herbeck; Mary-Lynn Brecht
Journal:  J Addict Dis       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.